Completed

The ICHOM Set of Patient-Centered Outcome Measures for Lung Cancer is the result of hard work by a group of leading physicians, measurement experts and patients. It is our recommendation of the outcomes that matter most to patients with Lung Cancer. We urge all providers around the world to start measuring these outcomes to better understand how to improve the lives of their patients.

  1. Includes major surgical complications, major radiation complications, and major systemic therapy complications. Recorded via the Common Terminology Criteria for Adverse Events (CTCAE), version 4.0
  2. Recorded via the Eastern Cooperative Oncology Group (ECOG) score
  3. Recommended to track via the European Organization for Research and Treatment of Cancer Quality of Life Lung Cancer-Specific Questionnaire (EORTC QLQ-LC13)
  4. Recommended to track via the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30)
  5. Includes physical, emotional, cognitive, and social function and well-being 6 Includes treatment-related mortality and cause of death
  6. Includes treatment related mortality and cause of death

Premium Content

Enter your details below to gain access to this content.
Please note: You will need to enable cookies to download premium content

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
ICHOM Accreditation Product Logo

All of the basic information you need to implement ICHOM Sets is available in the links above. However, for a faster, more easily integrated process, we offer digitised versions of the Set measures. These are designed for immediate upload to existing EMR systems. This is available as part of our Accreditation package, which recognises your work in putting patient outcomes at the heart of treatment.

Find Out More

Team that developed this set

AUSTRALIA
Robert Stirling | Monash University

BELGIUM
Jan van Meerbeeck | Antwerp University Hospital

BRAZIL
Clarissa Baldatto | Clínicas Oncológicas Integradas

NETHERLANDS
Franz Schramel | St. Antonius Hospital
Suresh Senan | VU University Medical Centre Amsterdam
Michel Wouters | Netherlands Cancer Institute

UNITED KINGDOM
Matthew Baker*
David Baldwin | Nottingham University Hospitals
Diana Borthwick | Edinburgh Cancer Research Centre
Jesme Fox | Roy Castle Lung Cancer Foundation
Tom Haswell*
Mick Peake | University Hospital Leicester

UNITED STATES
Janet Abrahm | Dana-Farber Cancer Institute
David Carbone | Ohio State University Comprehensive Cancer Center
Aileen Chen | Dana-Farber Cancer Institute
Marianna Koczywas | City of Hope National Medical Center
Benjamin Kozower | University of Virginia Health System
Kimberley Mak | Dana-Farber Cancer Institute
Reza Mehran | MD Anderson Cancer Center

* Parent representative

Are you implementing ICHOM Sets?

If your are implementing ICHOM Sets, please help us understand more about your journey by filling in our Implementation Survey. Click on the link below to complete:

View Survey

Implementation Map

We would like to add you to our Implementation Map if you are implementing or have implemented ICHOM Sets. Please click on the button below for more information.

Find Out More